NCT05599204

Brief Summary

The study will be conducted to investigate the effect of Schroth method on balance in patients with the upper cross syndrome

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
40

participants targeted

Target at P25-P50 for not_applicable

Timeline
Completed

Started Oct 2022

Shorter than P25 for not_applicable

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

October 19, 2022

Completed
8 days until next milestone

Study Start

First participant enrolled

October 27, 2022

Completed
4 days until next milestone

First Posted

Study publicly available on registry

October 31, 2022

Completed
1 month until next milestone

Primary Completion

Last participant's last visit for primary outcome

December 5, 2022

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

December 5, 2022

Completed
Last Updated

February 16, 2023

Status Verified

February 1, 2023

Enrollment Period

1 month

First QC Date

October 19, 2022

Last Update Submit

February 15, 2023

Conditions

Keywords

Schroth Methodupper cross syndromebalance

Outcome Measures

Primary Outcomes (2)

  • stability index

    stability index will be measured by Biodex balance system

    up to four weeks

  • spinal curvature

    spinal mouse will be used to assess thoracic spine curvature. Total angle of the thoracic spine is 41-44 degree

    up to four weeks

Secondary Outcomes (5)

  • craniovertebral angle

    up to four weeks

  • pain intensity

    up to four weeks

  • neck function

    up to four weeks

  • Respiratory pulmonary functions

    up to four weeks

  • shoulder posture

    up to four weeks

Study Arms (2)

schroth exercise

EXPERIMENTAL

the patients will receive Schroth exercise twice a week for four weeks

Other: schroth exerciseOther: postural correction exercise

postural correction exercise

ACTIVE COMPARATOR

the patients will receive postural correction exercise twice a week for four weeks

Other: postural correction exercise

Interventions

the patients will receive the Schroth three-dimensional exercise. patient first assumes a posture in the cervico-cranial and shoulder girdle and the thoracic region is held in the correct posture. The patient inspires air into the concave side and during the exhalation phase isometric and isotonic muscle tensing occur. While the patient is breathing, the therapist should observe the posture and movement of the thoracic cage and diaphragm. Basic posture correction in sitting and walking and Sensorimotor training by the ball will be applied

schroth exercise

the patients will receive postural correction exercises, stretches, and exercises to the pectoralis major, elevator scapulae, upper trapezius, serratus anterior, rhomboids, and deep neck flexors. The stretches included sitting chair stretches, Brugger's, wall angels, and doorway stretches. The exercises included push up- plus, head-neck-retraction, and Kibler squeeze

postural correction exerciseschroth exercise

Eligibility Criteria

Age17 Years - 22 Years
Sexall
Healthy VolunteersNo
Age GroupsChild (0-17), Adult (18-64)

You may qualify if:

  • The patient's age ranged from 17 to 22 years
  • Body mass index between 20-25 kg/m2
  • The participants are diagnosed with upper cross syndrome
  • Patients with normal cognitive aspects willing and able to participate in a program safely

You may not qualify if:

  • The participants have experienced any recent trauma (within 3 months of the initial consultation)
  • The participant's primary complaint is that of headaches or facial pain.
  • Participants have any sort of structural abnormality in upper and middle back e.g., Scoliosis, or had a positive Adams test.
  • Participants who are taking anti-inflammatory or muscle relaxant medication had to have a three-day "wash out" period before participating in the study

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Faculty of physical therapy Cairo university

Giza, Egypt

Location

MeSH Terms

Conditions

Oculocerebral hypopigmentation syndrome type Preus

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
DOUBLE
Who Masked
INVESTIGATOR, OUTCOMES ASSESSOR
Masking Details
opaque sealed envelop
Purpose
TREATMENT
Intervention Model
PARALLEL
Model Details: Schroth exercise and postural correction group
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
principle investigator mariam omran grase

Study Record Dates

First Submitted

October 19, 2022

First Posted

October 31, 2022

Study Start

October 27, 2022

Primary Completion

December 5, 2022

Study Completion

December 5, 2022

Last Updated

February 16, 2023

Record last verified: 2023-02

Locations